|21 July, 2019

UAE Ministry of Health & Prevention takes part in CPHI pharmaceutical exhibition as sponsor and supportive partner

The Ministry of Health and Prevention (MoHAP) has signed a Memorandum of Understanding (MoU) with Informa-UBM EMEA, one of the world's largest conference and training organizers

UAE Ministry of Health Prevention takes part in CPHI pharmaceutical exhibition as sponsor and supportive partner

Dubai: The Ministry of Health and Prevention (MoHAP) has signed a Memorandum of Understanding (MoU) with Informa-UBM EMEA, one of the world’s largest conference and training organizers.

Under this MoU, MoHAP will be the sponsor and supportive partner of the “CPhI Exhibition & Conference” Middle East and Africa 2019. CPhI is the world’s largest pharma event at the local and international levels.

This year’s edition will take place at Abu Dhabi National Exhibition Centre from 16 - 18 September 2019.

The MoU was signed at MoHAP headquarters by HE Dr. Amin Hussein Al Amiri, Assistant Undersecretary of the Ministry of Health and Prevention’s Public Health Policy and Licenses, Dr. Kara Turner, Director-General of Informa-UBM EMEA.

The signing ceremony was also attended by Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department, Dr. Rasha Salama, Public Health Advisor, Dr. Rita Al Chalouhi, Pharmaceutical Advisor and a number of the company employees.

This agreement is valid during this year’s edition of CPhI Exhibition & Conference Middle East and Africa 2019, which is witnessing the participation of 294 exhibitors and hosting over 3000 pharmaceutical suppliers and buyers.

While MoHAP will participate in the presentations and panel discussions, which will be held to introduce effective pharmaceutical ingredients, additives, and the most accurate chemicals used by manufacturers.

In addition to reviewing the pharmaceutical contract services in clinical trials, research and manufacturing contracts, vital services, information technology services, analytical services, and packaging contracts.

Strengthening the Pharmaceutical Sector

Dr. Ruqaya Al Bastaki, Director of MoHAP’s Drug Department, said: “We are pleased to sign this MoU with Informa-UBM EMEA. This agreement is constituting an impetus to realize our mutual ambitions to strengthen the UAE’s pharmaceutical industry by sponsoring and supporting one of the most important pharmaceutical exhibitions.

“This exhibition is forming an ideal platform for exploring the latest trends and challenges and it also provides high-level content and comprehensive insights into the development of future strategies in the pharmaceutical products sector,” Al Bastaki added.

She emphasized MoHAP’s keenness to enhance relations with the local and international companies and institutions and to actively participate in specialized conferences and exhibitions aimed at developing the UAE’s pharmaceutical sector, in view of the existence of many local and international companies in the country.

While Dr. Kara Turner said: “CPhI Middle East & Africa is the largest regional pharmaceutical gathering, with a large number of suppliers and buyers in the pharmaceutical field, featuring contracting services for machinery, equipment, and technology, and provides an online directory of pharmaceutical distributors and suppliers.”

-Ends-

For further information, please contact:
Heba Alshahed
Misbar Communications
00971505784522 heba.alshahed@misbar-me.com
Osama Al Ansari
Misbar Communications
00971509194522 Osama@misbar-me.com
Mahmoud Soliman
Misbar Communications
00971505874522 mahmoud.soliman@misbar-me.com 

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases